The US Parkinson's disease community demands prevention The Lancet Neurology ++... ++

The US Parkinson's disease community demands prevention The Lancet Neurology https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00173-0/fulltext?dgcid=raven_jbs_etoc_email Jun 2026 Volume 25Number 6p533-614 https://www.thelancet.com/journals/laneur/issue/vol25no6/PIIS1474-4422(26)X2004-X Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial Lotte Kjærsgaard, MDa ∙ Jonas Wiedemann, MSca ∙ Prof Wolfgang Singer, MDb ∙ Atsushi Takeda, MDc ∙ Anna-Karin Berger, PhDa ∙ Mimi Folden Flensburg, DVM PhDa ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00100-6/abstract?dgcid=raven_jbs_etoc_feature_laneur Safety, tolerability, and efficacy of acetazolamide in idiopathic normal pressure hydrocephalus (DRAIN) in Sweden: a randomised, double-blind, placebo-controlled, phase 2 trial Johan Virhammar, PhDa Send email to johan.virhammar@uu.se ∙ Oskar Fasth, MDa ∙ Maria Ekblom, Msca ∙ Oskar Ekman, MDa ∙ Nils Holmstrandb ∙ David Fällmar, PhDb ∙ et al. https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00126-2/abstract?dgcid=raven_jbs_etoc_feature_laneur